Mono Pharmacare IPO Details ( Mono Pharmacare Limited IPO Review )
(28 Aug 2023 – 30 Aug 2023)
Established in 1994, Mono Pharmacare Limited specializes in the marketing and distribution of pharmaceutical products. The company provides a range of healthcare items, including antibiotics, cough and cold medications, antifungal drugs, nutraceuticals, pain relievers, antacids, cardiac-diabetic medicines, and cosmocare products.
Collaborating with contract manufacturers, Mono Pharmacare produces pharmaceutical goods under the brand name DLS Export. In 2022, the company acquired DLS Export for ₹609 lakhs, aiming to expand its offerings in specific therapeutic domains.
As of February 28, 2023, Mono Pharmacare boasts a network of 168 pharmaceutical distributors and stockists. Furthermore, the company has catered to 3,036 customers and vendors, encompassing both retail pharmacy outlets and wholesalers.
Mono Pharmacare Limited Company Product
- Antibiotics
- Antifungal
- Anti Cough- Cold & Anti-allergic
- Antacid and Antiemetics
- Analgesics and Antipyretics
- Nutraceuticals
- Skincare
- Antiseptic
- Cardiac
- Diabetic & Cosmetics
Mono Pharmacare Limited IPO Competitive Strength
- Experienced promoters and management team with industry knowledge and an established track record
- Asset-light business model and competitive products
- Scalable Business Model
- Wide and diverse range of product offerings
Mono Pharmacare IPO Financials Performance ( Results )
Mono Pharmacare Limited Financial Information (Restated Consolidated)
All Amount in ₹ Lakhs
| Period Ended | Total Assets | Total Revenue | PAT | EPS (₹) | Net Worth | NAV (₹) | Reserves | Borrowing |
| 31-Mar-20 | 871.70 | 1,168.90 | 1.99 | 0.04 | 201.92 | – | – | 633.46 |
| 31-Mar-21 | 1,122.46 | 2,837.83 | 9.51 | 0.20 | 369.58 | 7.93 | – | 608.03 |
| 31-Mar-22 | 1,438.31 | 3,710.27 | 35.09 | 0.75 | 427.57 | 9.18 | – | 643.93 |
| 31-Mar-23 | 6,257.39 | 3,308.70 | 94.53 | 1.99 | 1368.57 | 19.92 | 131.71 | 3,992.70 |
Objective of IPO Issue
- To meet the working capital requirements
- General corporate purposes
- To meet the issue expenses
Mono Pharmacare IPO Basic Details
| IPO Date | Aug 28, 2023 to Aug 30, 2023 |
| Listing Date | Thursday, September 07, 2023 |
| Face Value | ₹10 per share |
| Price | ₹26 to ₹28 per share |
| Lot Size | 4000 Shares |
| Issue Size | 5,300,000 shares of ₹10 (aggregating up to ₹14.84 Cr) |
| Fresh Issue | 5,300,000 shares of ₹10 (aggregating up to ₹14.84 Cr) |
| Issue Type | Book Built Issue IPO |
| Listing At | NSE SME |
| Share holding pre issue | 12,368,564 |
| Share holding post issue | 17,668,564 |
| Company Promoters | Panilam Lakhatariya And Supal Lakhatariya |
Mono Pharmacare IPO Reservation
| QIB Shares Offered | 10% of the Net Issue |
| NII (HNI) Shares Offered | 45% of the Net Issue |
| Retail Shares Offered | 45% of the Net Issue |
Mono Pharmacare IPO Timetable
Mono Pharmacare IPO will open on August 28, 2023 and close on August 30, 2023. You can join Mono Pharmacare IPO at 10.00 A.M. to 5.00 p.m. Upto which mandate can be applied.
| Event | Date |
| Opening Date | 28 August 2023 (Monday) |
| Closing Date | 30 August 2023 (Wednesday) |
| Basis of Allotment | 4 September 2023 (Monday) |
| Initiation of Refunds | 5 September 2023 (Tuesday) |
| Credit of Shares to Demat | 6 September 2023 (Wednesday) |
| Listing Date | 7 September 2023 (Thursday) |
| Deadline for UPI mandate confirmation | 5 PM on 30 August 2023 |
Mono Pharmacare IPO Lot Size
For retail investors in Mono Pharmacare IPO, 4000 shares will come in 1 lot or the minimum investment will be ₹112,000. Retail-individual investors can apply for up to 1 lots or the maximum investment will be ₹112,000.
| Application | Lots | Shares | Amount |
| Retail (Min) | 1 | 4000 | ₹112,000 |
| Retail (Max) | 1 | 4000 | ₹112,000 |
| S-HNI (Min) | 2 | 8000 | ₹224,000 |
Mono Pharmacare IPO Promoter Holding
The company’s promoters include Panilam Lakhatariya And Supal Lakhatariya.
| Pre Issue Share Holding | 81.02% |
| Post Issue Share Holding | – |
Mono Pharmacare Ltd IPO Key Performance Indicator ( Valuation )
In the table given below, all the figures have been told according to the latest financial year.
| KPI | Values |
| Market Cap (₹ Cr.) | 49.47 |
| Earning Per Share (EPS) | ₹1.99 per Equity Share |
| Net Asset Value (NAV) | ₹19.92 per Equity Share |
| P/E Ratio (P/E) (x) | 40 |
| Return on Net Worth (RoNW) (%) | 9.01 |
| Return on equity (ROE) (%) | 9.01 |
| Return on Capital Employed (ROCE) (%) | 10.34 |
| Debt/Equity Ratio | 2.92 |
Mono Pharmacare Ltd Peer Comparison
P/E Ratio has been computed based on the closing market price of equity shares on the BSE on
March 31, 2023 divided by the Diluted EPS of August 11, 2023.
| Company Name | Consolidated/ Standalone | Face Value | EPS (₹) | P/E Ratio | RoNW (%) | NAV (₹) |
| Mono Pharmacare Limited | Standalone | 10 | 1.99 | 40 | 9.01 | 19.92 |
| Peer Group | ||||||
| Chandra Bhagat Pharma Limited | Standalone | 10 | 1.20 | 112.50 | 3.29% | 36.42 |
Mono Pharmacare IPO GMP Live Update, Kostak Rate day by day
| Date | GMP | Kostak | Subject to |
| 6 September 2023 | ₹4 | – | – |
| 5 September 2023 | ₹3 | – | – |
| 4 September 2023 | ₹3 | – | – |
| 3 September 2023 | ₹3 | – | – |
| 2 September 2023 | ₹3 | – | – |
| 1 September 2023 | ₹3 | – | – |
| 31 August 2023 | ₹3 | – | – |
| 30 August 2023 | ₹3 | – | – |
| 29 August 2023 | ₹0 | – | – |
| 28 August 2023 | ₹0 | – | – |
| 27 August 2023 | ₹0 | – | – |
| 26 August 2023 | ₹0 | – | – |
Mono Pharmacare IPO Detail Video:
Mono Pharmacare IPO Subscription Status (Bidding Detail)
The Mono Pharmacare IPO on August 30, 2023 at 7:30:00 PM was subscribed 13.42 times, with the retail category being subscribed 19.40 times, the NII (Non-Institutional Investor) category being subscribed 8.00 times, QIB (Qualified-Institutional Buyers) category being subscribed 10.89 times.
| Category | Subscription |
| QIB | 10.89x |
| NII | 8.00x |
| Retail | 19.40x |
| Total | 13.42x |
Mono Pharmacare IPO Prospectus
| Mono Pharmacare IPO DRHP | Download |
| Mono Pharmacare IPO RHP | Download |
| Mono Pharmacare IPO Anchor Investors Details PDF | Download |
Mono Pharmacare IPO Rating
| Our Rating | 2.0/5.0 |
Mono Pharmacare Company Contact Information
Mono Pharmacare Limited
Registered office: 1A, Krinkal Apartment Opp. Mahalaxmi Temple,
Paldi Ahmedabad -380007, Gujarat
Tel: +91-99780 41356
E-mail: cs@monopharmacareltd.com
Website: www.monopharmacareltd.com
Contact Person: Krupali Thakkar, Company Secretary and Compliance Officer
Promoters Of The Company: Panilam Lakhatariya And Supal Lakhatariya
Mono Pharmacare IPO Registrar
Bigshare Services Private Limited
Registered office: S6-2, 6th Floor, Pinnacle Business Park,
Next to Ahura Centre, Mahakali Caves Road, Andheri (East),
Mumbai –400 093, Maharashtra, India
Telephone: 022-6263 8200
Facsimile: 022-6263 8299
Email: ipo@bigshareonline.com
Investor grievance email: investor@bigshareonline.com
Contact Person: Swapnil Kate
Website: www.bigshareonline.com
SEBI Registration Number: INR000001385
CIN: U99999MH1994PTC076534
Mono Pharmacare IPO Lead Manager
Unistone Capital Private Limited
Registered office: A/305, Dynasty Business Park, Andheri Kurla Road,
Andheri East,Mumbai 400059, Maharashtra, India
Telephone: +91 98200 57533
Email: mb@unistonecapital.com
Website: www.unistonecapital.com
Investor grievance email: compliance@unistonecapital.com
Contact Person: Brijesh Parekh
SEBI registration number: INM000012449
CIN: U65999MH2019PTC330850
Mono Pharmacare IPO FAQs
What is the lot size of Mono Pharmacare IPO?
The total size of Mono Pharmacare IPO is ₹14.84 crores and this is a complete fresh Issue.
When will Mono Pharmacare IPO start?
Mono Pharmacare IPO will open from 28 August 2023 and IPO will close on 30 August 2023.
What is the open date of Mono Pharmacare IPO?
Mono Pharmacare IPO will open date from 28 August 2023.
What is the last date ( close date ) of Mono Pharmacare IPO?
Mono Pharmacare IPO will close from 30 August 2023.
What is the price band of Mono Pharmacare IPO?
Mono Pharmacare IPO price band is ₹26 to ₹28. ( Upper Price Band: ₹28, Lower Price Band: ₹26 )
What is the minimum amount required to apply for Mono Pharmacare IPO?
The minimum investment for retailers to apply for Mono Pharmacare IPO is ₹112,000 and the maximum investment is ₹112,000.
What is going on gray market premium of Mono Pharmacare IPO?
View gray market premium of Mono Pharmacare IPO by Clicking Here
How much is the GMP of Mono Pharmacare IPO?
Watch Mono Pharmacare IPO GMP Today: Click Here
What is the allotment date of Mono Pharmacare IPO?
The allotment date of Mono Pharmacare IPO is 4 September 2023.
How to check allotment status in Mono Pharmacare IPO?
To check the allotment status of Mono Pharmacare IPO, first of all go to the registrar website by clicking here, select your bad Mono Pharmacare IPO name or enter your bad application number, PAN number or client ID and click on submit. ( Video Link )
What is the listing date of Mono Pharmacare IPO?
The listing date of Mono Pharmacare IPO is 7 September 2023.
How much will be the listing gain in Mono Pharmacare IPO?
View listing gain of Mono Pharmacare IPO by Clicking Here
How much time Mono Pharmacare IPO is subscribed?
Total 13.42 times subscribed in Mono Pharmacare IPO out of which 19.40 times subscription was done in retail quota, 8.00 times subscription in NII quota and 10.89 times subscription in QIB quota.
How to apply for Mono Pharmacare IPO from Upstox?
Click Here to see how to apply for Mono Pharmacare IPO from Upstox. (step by step)
How to apply for Mono Pharmacare IPO from Zerodha?
Click Here to see how to apply for Mono Pharmacare IPO from Zerodha. (step by step)
How to apply for Mono Pharmacare IPO from Angle One?
Click Here to see how to apply for Mono Pharmacare IPO from Angle One. (step by step)
